Document is current
Any future updates will be listed below
-
Authors
Ahmed, Areeba
Sharma, Divija
Ungar, Benjamin
- License Information
-
More Information
Article History
Received: 13 May 2025
Revised: 13 May 2025
Accepted: 30 May 2025
First Online: 9 June 2025
Declarations
:
: Not applicable.
: BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Arcutis Biotherapeutics, Incyte, Rapt Therapeutics, Pfizer, and Sanofi. He is also a consultant for Arcutis Biotherapeutics, Bristol Myers Squibb, Castle Biosciences, Fresenius Kabi, Galderma, Janssen, Lilly, Pfizer, Primus Pharmaceuticals, Sanofi, and UCB. The other authors have no conflicts of interest.
